Dr. David-Alexandre Gros has been named chief strategy officer of Sanofi, effective September 1, 2011. He will report to Christopher A. Viehbacher, Sanofi's chief executive officer, and will join the Group Executive Committee. He will be based in Paris, France. Dr. Gros' position will cover all Group business development and acquisition activities as well as strategic planning, economic evaluation of projects, strategic intelligence, and alliance management.
Mr. Viehbacher remarked, “David-Alexandre brings a wealth of experience as a physician, strategic consultant and investment banker. He will be able to contribute significantly to the development and implementation of Sanofi’s strategy and transformation.”
Dr. Gros joins Sanofi after serving as an advisor to pharmaceutical, biotechnology and diagnostic companies as a Principal and founding member of the Healthcare Investment Banking division at Centerview Partners, in San Francisco, CA. He previously worked in clinical and health outcomes research at the Department of Urology of the Johns Hopkins Hospital from (1996-99), and as a Resident Physician at the University of Pennsylvania Health System (1999-2000), followed by a stretch at McKinsey & Co.’s Pharmaceuticals & Medical Products practice (2002-06). In late 2006, he joined Merrill Lynch as a vice president in Healthcare Investment Banking focusing on strategy, mergers & acquisitions and corporate finance, until joining Centerview Partners in mid-2009
New Chief Strategy Officer for Sanofi
By Gil Roth
Published July 28, 2011
blog comments powered by Disqus